Asthika Goonewardene
Stock Analyst at Truist Securities
(1.43)
# 3,534
Out of 5,044 analysts
92
Total ratings
40.91%
Success rate
-10.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $18.60 | +109.68% | 2 | Oct 7, 2025 | |
| MRUS Merus | Downgrades: Hold | $88 → $97 | $94.60 | +2.54% | 3 | Sep 29, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $27.35 | +265.63% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $57.99 | +70.72% | 1 | Sep 5, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $250 → $36 | $10.59 | +239.94% | 5 | Aug 14, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $108 → $127 | $120.47 | +5.42% | 2 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $39.99 | +22.53% | 11 | Jul 29, 2025 | |
| GMAB Genmab | Maintains: Buy | $45 → $46 | $29.03 | +58.46% | 15 | Jul 8, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $106.05 | +46.16% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $32.12 | +121.05% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.23 | +713.01% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.65 | +506.06% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.31 | +549.35% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.46 | +79.86% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $86.70 | +56.86% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $1.16 | +1,193.10% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.71 | +133.92% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $2.45 | +675.51% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.90 | +2,894.01% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $19.87 | +503.93% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $2.09 | +2,770.81% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $9.27 | +1,841.73% | 4 | Aug 23, 2022 |
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $18.60
Upside: +109.68%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $88 → $97
Current: $94.60
Upside: +2.54%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $27.35
Upside: +265.63%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $57.99
Upside: +70.72%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $250 → $36
Current: $10.59
Upside: +239.94%
Gilead Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $108 → $127
Current: $120.47
Upside: +5.42%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $39.99
Upside: +22.53%
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $29.03
Upside: +58.46%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $106.05
Upside: +46.16%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $32.12
Upside: +121.05%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.23
Upside: +713.01%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.65
Upside: +506.06%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.31
Upside: +549.35%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $19.46
Upside: +79.86%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $86.70
Upside: +56.86%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $1.16
Upside: +1,193.10%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.71
Upside: +133.92%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $2.45
Upside: +675.51%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.90
Upside: +2,894.01%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $19.87
Upside: +503.93%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.09
Upside: +2,770.81%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $9.27
Upside: +1,841.73%